Lipitor, Atorvastatin Newswire (Page 8)

Lipitor, Atorvastatin Newswire (Page 8)

Comprehensive Real-Time News Feed for Lipitor, Atorvastatin (generic). (Page 8)

Results 141 - 160 of 1,016 in Lipitor, Atorvastatin (generic)

  1. STADA Arzneimittel AG (SAZ) Given a a 66.25 Price Target by Warburg Research AnalystsRead the original story w/Photo

    Aug 30, 2017 | AmericanBankingNews.com

    The firm currently has a "sell" rating on the stock. Several other research analysts have also recently weighed in on SAZ.

    Comment?

  2. Alarm fatigue is problem. Here's a pragmatic solution.Read the original story w/Photo

    Aug 30, 2017 | Kevin, M.D.

    I missed a drug interaction warning the other day when I prescribed a sulfa antibiotic to Barton, a COPD patient who is also taking dofetilide, an uncommon antiarrhythmic. The big red warning had popped up on my computer screen, but I x-ed it away with my right thumb on the trackball without reading the warning.

    Comment?

  3. Amgen Release: New Virtual Histology Sub-Study Evaluates Impact Of...Read the original story

    Aug 29, 2017 | BioSpace

    While virtual histology demonstrated an increase in dense calcium in coronary artery plaques in both the statin and Repatha arms, it did not detect a statistically significant difference between the two treatment groups. However, the observed directional trend in increased dense calcium with corresponding reduction in low-density lipoprotein cholesterol is consistent with findings from previous statin studies.1 The sub-study also showed reductions in LDL-C and percent atheroma volume consistent with the primary GLAGOV results.

    Comment?

  4. The Doctor Game: Is increasing dosages of cholesterol-lowering drugs prudent?Read the original story w/Photo

    Aug 2, 2017 | SooToday

    Do you remember the story about the straw that broke the camel's back? How the camel's owner kept loading more and more straw on the animal's back. Eventually one more straw broke the poor creature's back.

    Comment?

  5. GIFFORD-JONES: Side effects can increase with higher doses of CLDsRead the original story w/Photo

    Aug 29, 2017 | The Guardian

    The camel's owner kept loading more and more straw on the animal's back and eventually one more straw broke that poor creature's back. Pushing your luck too far is a poor idea.

    Comment?

  6. Merck debates seeking approval for - somewhat effective'Read the original story w/Photo

    Aug 29, 2017 | SFGate

    After 13 years and probably hundreds of millions of dollars testing a drug found "somewhat effective," Merck must decide whether to pursue FDA approval. After 13 years and probably hundreds of millions of dollars testing a drug found "somewhat effective," Merck must decide whether to pursue FDA approval.

    Comment?

  7. Merck Announces Results of REVEAL Outcomes Study of Anacetrapib,...Read the original story w/Photo

    Aug 28, 2017 | Drugs.com

    August 29, 2017 --Merck , known as MSD outside the U.S. and Canada, and researchers in the Clinical Trial Service Unit at the University of Oxford, today announced the publication and presentation of results from the REVEAL outcomes study of anacetrapib, Merck's investigational cholesteryl ester transfer protein inhibitor. In the study of 30,449 patients with atherosclerotic vascular disease receiving LDL-C lowering treatment with atorvastatin, anacetrapib significantly reduced the risk of major coronary events by 9 percent relative to placebo .

    Comment?

  8. Merck faces questions about cholesterol drug after mediocre findingsRead the original story w/Photo

    Aug 29, 2017 | Star Tribune

    But the drug, anacetrapib, only reduced those complications by 9 percent. Now Merck, which has spent 13 years and likely hundreds of millions of dollars testing the drug, has to decide whether to spend even more to seek approval from regulators and persuade people to buy it in a market full of cholesterol drugs.

    Comment?

  9. New Cholesterol Drugs Vastly Overpriced, Study ContendsRead the original story w/Photo

    Aug 23, 2017 | MedicineNet

    Are new medicines for people with out-of-control cholesterol wildly overpriced? It's a question that's sparking debate among consumers and providers of care. Now, researchers at the University of California, San Francisco report that the price of these drugs -- called PCSK9 inhibitors -- would have to be slashed by a whopping 71 percent to be deemed cost-effective.

    Comment?

  10. 30 Great Stocks of All TimeRead the original story w/Photo

    Aug 23, 2017 | Kiplinger Online

    A finance professor made a startling discovery about the stock market: Over a 90-year span, 96% of all stocks collectively performed no better than risk-free 1-month Treasury bills. After analyzing the lifetime returns of 25,782 common stocks, Hendrik Bessembinder determined that just 1,000 of those stocks - or about 4% of the total - generated all of the nearly $32 trillion in wealth created by the stock market between July 1926 and December 2015.

    Comment?

  11. New Cholesterol Drugs Vastly Overpriced: StudyRead the original story w/Photo

    Aug 23, 2017 | News Max

    Are new medicines for people with out-of-control cholesterol wildly overpriced? It's a question that's sparking debate among consumers and providers of care. Now, researchers at the University of California, San Francisco report that the price of these drugs -- called PCSK9 inhibitors -- would have to be slashed by a whopping 71 percent to be deemed cost-effective.

    Comment?

  12. Next Avenue: Most Americans can't kick this habit, and it's killing themRead the original story w/Photo

    Aug 23, 2017 | MarketWatch

    With obesity on the rise and high rates of Type 2 diabetes, more people are attempting to give up sugar. It isn't easy.

    Comment?

  13. New Cholesterol Drugs Vastly Overpriced, Study ContendsRead the original story w/Photo

    Aug 22, 2017 | HON

    Are new medicines for people with out-of-control cholesterol wildly overpriced? It's a question that's sparking debate among consumers and providers of care. Now, researchers at the University of California, San Francisco report that the price of these drugs -- called PCSK9 inhibitors -- would have to be slashed by a whopping 71 percent to be deemed cost-effective.

    Comment?

  14. Buffalo's Oldest Tree To Get A BoostRead the original story w/Photo

    Aug 22, 2017 | WBEN-AM Buffalo

    The sycamore, believed to be approx.. 300 years old, stands in front of 404 Franklin Street in the city, it's large canopy shading the sidewalk, but its trunk showing severe scabbing.

    Comment?

  15. Adverse events associated with unblinded, but not with blinded,...Read the original story

    Aug 21, 2017 | CiteULike

    Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm : a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase. Lancet , Vol.

    Comment?

  16. Here's How Much $10,000 Invested in Pfizer in 1977 Is Worth NowRead the original story w/Photo

    Aug 20, 2017 | The Motley Fool

    Forty years is a long time. But it's not an unimaginably long time. For many Americans, 40 years is roughly the length of time they will spend or have spent in the workforce.

    Comment?

  17. How to Spend $1.6 Trillion? Start With an Obscure German DrugmakerRead the original story w/Photo

    Aug 16, 2017 | Bloomberg

    Stada Arzneimittel AG is about as unexciting as a company can be. Based in a sleepy spa town just outside Frankfurt, the drugmaker makes Snup nose spray, Grippostad cold pills, and other branded drugs for common ailments, as well as low-cost copies of medications such as cholesterol drug Lipitor and pain balm Voltaren.

    Comment?

  18. Vascular surgeon opts for beef, not statins, to lower cholesterolRead the original story w/Photo

    Aug 2, 2017 | Beef Magazine

    Could beef eliminate the need for cholesterol-lowering drugs and reduce the incidence of diabetes? Read this patient's testimony to learn more. For too long, beef has been demonized, and that's why I get so excited where I see it touted as a health food in the mainstream media.

    Comment?

  19. Does Lipitor Help Rheumatoid Arthritis?Read the original story w/Photo

    Aug 15, 2017 | MedicineNet

    Melissa Conrad Stppler, MD, is a U.S. board-certified Anatomic Pathologist with subspecialty training in the fields of Experimental and Molecular Pathology. Dr. Stppler's educational background includes a BA with Highest Distinction from the University of Virginia and an MD from the University of North Carolina.

    Comment?

  20. Facing deadlines, drug makers move to beef up defenses against counterfeit medicationsRead the original story w/Photo

    Aug 14, 2017 | Boston.com

    Counterfeit drugs look a lot like the real deal, but can contain too little or none of the active ingredients that make a drug work. Or worse, a counterfeit drug can have toxic compounds.

    Comment?